Status:
COMPLETED
Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ministry of Health, France
UNICANCER
Conditions:
Compensated Cirrhosis
Eligibility:
All Genders
30-75 years
Phase:
PHASE3
Brief Summary
Liver carcinoma is becoming the main complication of cirrhosis. Treatment of symptomatic or large tumors is disappointing. Regular ultrasonographic screening of small (curable) tumors is currently rec...
Detailed Description
Patients: All consecutive patients with compensated HBV, HCV, alcohol or hemochromatosis-related cirrhosis (without any previous clinical complication including liver cancer). Randomization: factoria...
Eligibility Criteria
Inclusion
- Compensated cirrhosis
Exclusion
- Antecedent of osmic acid synoviorthesis or of isotopic synoviorthesis of the studied knee
- Intra-articular injection of triamcinolone hexacetonide in three months preceding the inclusion or by a different corticoid in the month preceding the inclusion
- Evolutionary infectious or neoplastic pathology
Key Trial Info
Start Date :
July 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00190385
Start Date
July 1 2000
End Date
July 1 2009
Last Update
February 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Jean Verdier
Paris, Île-de-France Region, France, 75010